메뉴 건너뛰기




Volumn 60, Issue 9, 2014, Pages 720-724

AGEs and RAGE - Advanced glycation end-products and their receptor in questions and answers;AGEs a RAGE - konečné produkty pokročilé glykace a jejich receptor v otázkách a odpovědích

Author keywords

Advanced glycation end products; Ages; Carbonyl stress; Diabetes mellitus; Inflammation; Oxidative stress; RAGE; Receptor for Ages; SRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; HEXOSAMINE; HIGH MOBILITY GROUP B1 PROTEIN; POLYOL; PROTEIN KINASE C;

EID: 84908428515     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (48)
  • 1
    • 0000916315 scopus 로고
    • Action des acides amines sur les sucres; Formacion des melaniodines par vole methodique
    • Maillard LC. Action des acides amines sur les sucres; formacion des melaniodines par vole methodique. CR Acad Scl 1912; 154:66-68.
    • (1912) CR Acad Scl , vol.154 , pp. 66-68
    • Maillard, L.C.1
  • 2
    • 0021683315 scopus 로고
    • Nonenzymatic glycation of human lens crystatlin. Effect of aging and diabetes mellitus
    • Garlick RL, Mazer JS, Chylack jr. LT et al. Nonenzymatic glycation of human lens crystatlin. Effect of aging and diabetes mellitus. J Clin Invest 1984; 74(5): 1742-1749.
    • (1984) J Clin Invest , vol.74 , Issue.5 , pp. 1742-1749
    • Garlick, R.L.1    Mazer, J.S.2    Chylack, L.T.3
  • 3
    • 0021231172 scopus 로고
    • Nonenzymatic glycosylation and the pathogenesis of diabetic complications
    • Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101(4): 527-537.
    • (1984) Ann Intern Med , vol.101 , Issue.4 , pp. 527-537
    • Brownlee, M.1    Vlassara, H.2    Cerami, A.3
  • 4
    • 0022523006 scopus 로고
    • Glycation of skin collagen in type i diabetes mellitus. Correlation with long-Term complications
    • Vishwanath V, Frank KE, Elmets CA et al. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-Term complications. Diabetes 1986; 35(8): 916-921.
    • (1986) Diabetes , vol.35 , Issue.8 , pp. 916-921
    • Vishwanath, V.1    Frank, K.E.2    Elmets, C.A.3
  • 5
    • 0025938891 scopus 로고
    • Advanced glycosylation end products in patients with diabetic nephropathy
    • Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325(12): 836-842.
    • (1991) N Engl J Med , vol.325 , Issue.12 , pp. 836-842
    • Makita, Z.1    Radoff, S.2    Rayfield, E.J.3
  • 7
    • 0027963568 scopus 로고
    • Serum advanced glycosylation end products: A new class of uremic toxins?
    • Vlassara H. Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif 1994; 12(1): 54-59.
    • (1994) Blood Purif , vol.12 , Issue.1 , pp. 54-59
    • Vlassara, H.1
  • 8
    • 0028363366 scopus 로고
    • Advanced glycation end products contribute to amyloidosis in Alzheimer disease
    • Vitek MP, Bhattacharya K, Glendening JM et al. Advanced glycation end products contribute to amyloidosis In Alzheimer disease. Proc Natl Acad Scl USA 1994; 91(11): 4766-4770.
    • (1994) Proc Natl Acad Scl USA , vol.91 , Issue.11 , pp. 4766-4770
    • Vitek, M.P.1    Bhattacharya, K.2    Glendening, J.M.3
  • 9
    • 0026659883 scopus 로고
    • Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
    • Neeper M, Schmidt AM, Brett J et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267(21): 14998-15004.
    • (1992) J Biol Chem , vol.267 , Issue.21 , pp. 14998-15004
    • Neeper, M.1    Schmidt, A.M.2    Brett, J.3
  • 10
    • 64749107607 scopus 로고    scopus 로고
    • RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation
    • Dostupne z DOI
    • Sparvero LJ, Asafu-Adjei D, Kang R et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009; 7:17. Dostupne z DOI: http://doi: 10.1186/1479-5876-7-17.
    • (2009) J Transl Med , vol.7 , pp. 17
    • Sparvero, L.J.1    Asafu-Adjei, D.2    Kang, R.3
  • 11
    • 77953716356 scopus 로고    scopus 로고
    • Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase i genes in patients with pancreas cancer
    • Krechler T, Jáchymová M, Mestek O et al. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes In patients with pancreas cancer. Clin Bio-chem 2010; 43(10-11): 882-886.
    • (2010) Clin Bio-chem , vol.43 , Issue.10-11 , pp. 882-886
    • Krechler, T.1    Jáchymová, M.2    Mestek, O.3
  • 12
    • 0032910949 scopus 로고    scopus 로고
    • Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyt stress" in long-Term uremic complications
    • Miyata T, van Ypersele de Strihou C, Kurokawa K et al. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyt stress" in long-Term uremic complications. Kidney Int 1999; 55(2): 389-399.
    • (1999) Kidney Int , vol.55 , Issue.2 , pp. 389-399
    • Miyata, T.1    Van Ypersele De Strihou, C.2    Kurokawa, K.3
  • 13
    • 0017387996 scopus 로고
    • Structure of carbohydrate of hemoglobin Ale
    • Koenlg RJ, Blobsteln SH, Cerami A. Structure of carbohydrate of hemoglobin Ale. J Biol Chem 1977; 252(9): 2992-2997.
    • (1977) J Biol Chem , vol.252 , Issue.9 , pp. 2992-2997
    • Koenlg, R.J.1    Blobsteln, S.H.2    Cerami, A.3
  • 14
    • 34948841484 scopus 로고    scopus 로고
    • Evidence against dietary advanced glycation endproducts being a risk to human health
    • Ames JM. Evidence against dietary advanced glycation endproducts being a risk to human health. Mol Nutr Food Res 2007; 51(9): 1085-1090.
    • (2007) Mol Nutr Food Res , vol.51 , Issue.9 , pp. 1085-1090
    • Ames, J.M.1
  • 15
    • 34948836778 scopus 로고    scopus 로고
    • Dietary advanced glycation endproducts (AGEs) and their health effects - PRO
    • Sebeková K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects - PRO. Mol Nutr Food Res 2007; 51(9): 1079-1084.
    • (2007) Mol Nutr Food Res , vol.51 , Issue.9 , pp. 1079-1084
    • Sebeková, K.1    Somoza, V.2
  • 16
    • 0030992848 scopus 로고    scopus 로고
    • Orally absorbed reactive glycation products (glycotoxins): An enviromantal risk factor in diabetic nephropathy
    • Koschinski T, He CJ, Mitsuhashi T et al. Orally absorbed reactive glycation products (glycotoxins): An enviromantal risk factor in diabetic nephropathy. Proc Natl Acad Scl USA 1997; 94(12): 6474-6479.
    • (1997) Proc Natl Acad Scl USA , vol.94 , Issue.12 , pp. 6474-6479
    • Koschinski, T.1    He, C.J.2    Mitsuhashi, T.3
  • 17
    • 0037180567 scopus 로고    scopus 로고
    • Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
    • Vlassara H, Cai W, Crandall J et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002; 99(24): 15596-15601.
    • (2002) Proc Natl Acad Sci USA , vol.99 , Issue.24 , pp. 15596-15601
    • Vlassara, H.1    Cai, W.2    Crandall, J.3
  • 19
    • 0035104096 scopus 로고    scopus 로고
    • Metabolic transit and in vivo effects of me-lanoidins and precursor compounds deriving from the Maillard reaction
    • Faist V, Ebersdobler HF. Metabolic transit and In vivo effects of me-lanoidins and precursor compounds deriving from the Maillard reaction. Ann Nutr Metab 2001; 45(1): 1-12.
    • (2001) Ann Nutr Metab , vol.45 , Issue.1 , pp. 1-12
    • Faist, V.1    Ebersdobler, H.F.2
  • 20
    • 0033603241 scopus 로고    scopus 로고
    • RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S1OO/calgranulin polypeptides
    • Hofmann MA, Drury S, Fu C et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S1OO/calgranulin polypeptides. Cell 1999; 97(7): 889-901.
    • (1999) Cell , vol.97 , Issue.7 , pp. 889-901
    • Hofmann, M.A.1    Drury, S.2    Fu, C.3
  • 21
    • 0028851635 scopus 로고
    • The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterln. Mediation of neurite outgrowth and co-expression of rage and amphoterln in the developing nervous system
    • Hori O, Brett J, Slattery T et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterln. Mediation of neurite outgrowth and co-expression of rage and amphoterln in the developing nervous system. J Biol Chem 1995; 270(43): 25752-25761.
    • (1995) J Biol Chem , vol.270 , Issue.43 , pp. 25752-25761
    • Hori, O.1    Brett, J.2    Slattery, T.3
  • 22
    • 0013615899 scopus 로고    scopus 로고
    • RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
    • Yan SD, Chen X, Fu J et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382 (6593): 685-691.
    • (1996) Nature , vol.382 , Issue.6593 , pp. 685-691
    • Yan, S.D.1    Chen, X.2    Fu, J.3
  • 23
    • 9244227589 scopus 로고    scopus 로고
    • A novel calcium-binding protein in amniotic fluid, CAAF1: Its molecular cloning and tissue distribution
    • Hitoml J, Yamaguchi K, Kikuchi Y et al. A novel calcium-binding protein in amniotic fluid, CAAF1: its molecular cloning and tissue distribution. J Cell Scl 1996; 109(Pt 4): 805-815.
    • (1996) J Cell Scl , vol.109 , pp. 805-815
    • Hitoml, J.1    Yamaguchi, K.2    Kikuchi, Y.3
  • 24
    • 33845951211 scopus 로고    scopus 로고
    • DAMPs PAMPs and alarmins: All we need to know about danger
    • Bianchl ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007; 81(1): 1-5.
    • (2007) J Leukoc Biol , vol.81 , Issue.1 , pp. 1-5
    • Bianchl, M.E.1
  • 25
    • 67349232760 scopus 로고    scopus 로고
    • Human S100A12: A novel key player in inflammation?
    • Pietzsch J, Hoppmann S. Human S100A12: A novel key player in Inflammation? Amino Acids 2009; 36(3): 381-389.
    • (2009) Amino Acids , vol.36 , Issue.3 , pp. 381-389
    • Pietzsch, J.1    Hoppmann, S.2
  • 26
  • 27
    • 57549113882 scopus 로고    scopus 로고
    • Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway Implications for diabetic atherosclerosis
    • Hodgkinson CP, Laxton RC, Patel K et al. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway Implications for diabetic atherosclerosis. Arterioscler Thromb Vase Biol 2008; 28(12): 2275-2281.
    • (2008) Arterioscler Thromb Vase Biol , vol.28 , Issue.12 , pp. 2275-2281
    • Hodgkinson, C.P.1    Laxton, R.C.2    Patel, K.3
  • 28
    • 0035668462 scopus 로고    scopus 로고
    • The AGE-receptor in the pathogenesis of diabetic complications
    • Vlassara H. The AGE-receptor In the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001; 17(6): 436-443.
    • (2001) Diabetes Metab Res Rev , vol.17 , Issue.6 , pp. 436-443
    • Vlassara, H.1
  • 29
    • 33645461206 scopus 로고    scopus 로고
    • High mobility group box 1 protein Interacts with multiple Toll-like receptors
    • Park JS, Gamboni-Robertson F, He Q et al. High mobility group box 1 protein Interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290(3): C917-C924.
    • (2006) Am J Physiol Cell Physiol , vol.290 , Issue.3 , pp. C917-C924
    • Park, J.S.1    Gamboni-Robertson, F.2    He, Q.3
  • 30
    • 2942756123 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
    • Uliensiek B, Weigand MA, Bierhaus A et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004; 113(11): 1641-1650.
    • (2004) J Clin Invest , vol.113 , Issue.11 , pp. 1641-1650
    • Uliensiek, B.1    Weigand, M.A.2    Bierhaus, A.3
  • 31
    • 0034947508 scopus 로고    scopus 로고
    • Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
    • Yamamoto Y, Kato I, Doi T et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice, J Clin Invest 2001; 108(2): 261-268
    • (2001) J Clin Invest , vol.108 , Issue.2 , pp. 261-268
    • Yamamoto, Y.1    Kato, I.2    Doi, T.3
  • 32
    • 0034993801 scopus 로고    scopus 로고
    • Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy
    • Hudson Bl, Stickland MH, Futers TS et al. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50(6): 1505-1511.
    • (2001) Diabetes , vol.50 , Issue.6 , pp. 1505-1511
    • Hudson, B.L.1    Stickland, M.H.2    Futers, T.S.3
  • 33
    • 20844442808 scopus 로고    scopus 로고
    • Haplotype analysis of the RAGE gene: Identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
    • Kankova K, Stejskalová A, Hertlová M et al. Haplotype analysis of the RAGE gene: Identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20(6): 1093-1102.
    • (2005) Nephrol Dial Transplant , vol.20 , Issue.6 , pp. 1093-1102
    • Kankova, K.1    Stejskalová, A.2    Hertlová, M.3
  • 34
    • 43249092154 scopus 로고    scopus 로고
    • Identification, classification, and expression of RAGE gene splice variants
    • Hudson Bl, Carter AM, Harja E et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J 2008; 22(5): 1572-1580.
    • (2008) FASEB J , vol.22 , Issue.5 , pp. 1572-1580
    • Hudson, B.L.1    Carter, A.M.2    Harja, E.3
  • 35
    • 58149101483 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products is subjected to protein ectodomain shedding by meta-lloprotelnases
    • Zhang L, Bukulin M, Kojro E et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by meta-lloprotelnases. J Biol Chem 2008,-283 (51): 35507-35516.
    • (2008) J Biol Chem , vol.283 , Issue.51 , pp. 35507-35516
    • Zhang, L.1    Bukulin, M.2    Kojro, E.3
  • 36
    • 79958743636 scopus 로고    scopus 로고
    • The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparaglne 81: Comparison of wild-Type rage with the G82S polymorphic variant
    • Park SJ, Kleffmann T, Hessian PA. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparaglne 81: comparison of wild-Type rage with the G82S polymorphic variant. J Biol Chem 2011; 286(24): 21384-21392.
    • (2011) J Biol Chem , vol.286 , Issue.24 , pp. 21384-21392
    • Park, S.J.1    Kleffmann, T.2    Hessian, P.A.3
  • 37
    • 34548542837 scopus 로고    scopus 로고
    • De-N-glycosylation or G82S mutation of RAGE sensitizes its Interaction with advanced glycation endproducts
    • Osawa M, Yamamoto Y, Munesue S et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its Interaction with advanced glycation endproducts. Biochim Biophys Acta 2007; 1770(10): 1468-1474.
    • (2007) Biochim Biophys Acta , vol.1770 , Issue.10 , pp. 1468-1474
    • Osawa, M.1    Yamamoto, Y.2    Munesue, S.3
  • 38
    • 34547830269 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products - Soluble form and gene polymorphisms in chronic haemodlalysls patients
    • Kalousová M, Jáchymová M, Mestek O et al. Receptor for advanced glycation end products - soluble form and gene polymorphisms In chronic haemodlalysls patients. Nephrol Dial Transplant 2007; 22(7): 2020-2026.
    • (2007) Nephrol Dial Transplant , vol.22 , Issue.7 , pp. 2020-2026
    • Kalousová, M.1    Jáchymová, M.2    Mestek, O.3
  • 39
    • 33846044183 scopus 로고    scopus 로고
    • Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans
    • Jang Y, Kim JY, Kang SM et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 2007; 56(2): 199-205.
    • (2007) Metabolism , vol.56 , Issue.2 , pp. 199-205
    • Jang, Y.1    Kim, J.Y.2    Kang, S.M.3
  • 40
    • 77950205352 scopus 로고    scopus 로고
    • Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients
    • Kalousová M, Jáchymová M, Germanová A et al. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney Blood Press Res 2010; 33(1): 30-36.
    • (2010) Kidney Blood Press Res , vol.33 , Issue.1 , pp. 30-36
    • Kalousová, M.1    Jáchymová, M.2    Germanová, A.3
  • 41
    • 80052622673 scopus 로고    scopus 로고
    • Glyoxalase i polymorphism rs2736654 causing the AlalllGlu substitution modulates enzyme activity - Implications for autism
    • Barua M, Jenkins EC, Chen W et al. Glyoxalase I polymorphism rs2736654 causing the AlalllGlu substitution modulates enzyme activity - implications for autism. Autism Res 2011; 4(4): 262-270.
    • (2011) Autism Res , vol.4 , Issue.4 , pp. 262-270
    • Barua, M.1    Jenkins, E.C.2    Chen, W.3
  • 42
    • 84908419309 scopus 로고    scopus 로고
    • Patobiochemle ve schématech
    • Publishing: Praha
    • Kalousová M et al. Patobiochemle ve schématech. Grada Publishing: Praha 2006. ISBN 80-247-1522-8.
    • (2006) Grada
    • Kalousová, M.1
  • 43
    • 84908454813 scopus 로고    scopus 로고
    • Uremické toxiny - základnl charakteristika
    • Kalousová M. Uremické toxiny - základnl charakteristika. Farmako-Teraple review 2014; 7:4.
    • (2014) Farmako-Teraple Review , vol.7 , pp. 4
    • Kalousová, M.1
  • 44
    • 0142058743 scopus 로고    scopus 로고
    • Pyridoxamine, an Inhibitor of advanced glycation and lipoxidation reactions: A novel therapy for treatment of diabetic complications
    • Metz TO, Alderson NL, Thorpe SR et al. Pyridoxamine, an Inhibitor of advanced glycation and lipoxidation reactions: A novel therapy for treatment of diabetic complications. Arch Biochem Biophys 2003; 419(1): 41-49.
    • (2003) Arch Biochem Biophys , vol.419 , Issue.1 , pp. 41-49
    • Metz, T.O.1    Alderson, N.L.2    Thorpe, S.R.3
  • 45
    • 33845295849 scopus 로고    scopus 로고
    • Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes
    • Stirban A, Negrean M, Stratmann B et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006; 29(9): 2064-2071.
    • (2006) Diabetes Care , vol.29 , Issue.9 , pp. 2064-2071
    • Stirban, A.1    Negrean, M.2    Stratmann, B.3
  • 46
    • 84862223183 scopus 로고    scopus 로고
    • Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease
    • Vlassara H, Uribarri J, Cai Wet al. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products In diabetic kidney disease. Clin J Am Soc Nephrol 2012; 7(6): 934-942.
    • (2012) Clin J Am Soc Nephrol , vol.7 , Issue.6 , pp. 934-942
    • Vlassara, H.1    Uribarri, J.2    Cai, W.3
  • 47
    • 33750440810 scopus 로고    scopus 로고
    • Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure
    • Ueda S, Yamagishi S, Takeuchi M et al. Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure. Mol Med 2006; 12(7-8): 180-184.
    • (2006) Mol Med , vol.12 , Issue.7-8 , pp. 180-184
    • Ueda, S.1    Yamagishi, S.2    Takeuchi, M.3
  • 48
    • 35348922424 scopus 로고    scopus 로고
    • Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes
    • Coughlan MT, Forbes JM, Cooper ME. Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. Kidney Int 2007; 72(Suppl 106): S54-S60.
    • (2007) Kidney Int , vol.72 , pp. S54-S60
    • Coughlan, M.T.1    Forbes, J.M.2    Cooper, M.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.